GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $639,000 | -1.2% | 14,678 | 0.0% | 0.15% | +6.6% |
| Q4 2021 | $647,000 | +15.3% | 14,678 | 0.0% | 0.14% | +6.2% |
| Q3 2021 | $561,000 | -3.9% | 14,678 | 0.0% | 0.13% | -3.0% |
| Q2 2021 | $584,000 | +17.3% | 14,678 | +5.2% | 0.13% | +8.1% |
| Q1 2021 | $498,000 | -3.1% | 13,958 | 0.0% | 0.12% | -6.1% |
| Q4 2020 | $514,000 | -11.1% | 13,958 | -9.1% | 0.13% | -25.1% |
| Q3 2020 | $578,000 | -7.7% | 15,358 | 0.0% | 0.18% | -15.9% |
| Q2 2020 | $626,000 | +7.6% | 15,358 | 0.0% | 0.21% | -16.8% |
| Q1 2020 | $582,000 | -12.2% | 15,358 | +8.9% | 0.25% | +15.2% |
| Q4 2019 | $663,000 | +39.9% | 14,100 | +27.0% | 0.22% | +33.1% |
| Q3 2019 | $474,000 | +6.8% | 11,100 | 0.0% | 0.16% | +11.6% |
| Q2 2019 | $444,000 | +47.5% | 11,100 | +54.2% | 0.15% | +53.7% |
| Q1 2019 | $301,000 | +9.5% | 7,200 | 0.0% | 0.10% | -9.5% |
| Q4 2018 | $275,000 | -14.9% | 7,200 | -4.0% | 0.10% | 0.0% |
| Q3 2016 | $323,000 | – | 7,500 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |